Renovaro Biosciences Inc (RENB) — Financial Flexibility Index
Renovaro Biosciences Inc (RENB) has a Financial Flexibility Index of -0.06x as of June 2025. Free cash flow of $-1.81 Million (operating CF $-1.81 Million minus capex $0.00) represents 0% of total liabilities ($29.58 Million). Check Renovaro Biosciences Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Renovaro Biosciences Inc Financial Flexibility Index (2012–2025)
Historical Financial Flexibility Index trend for Renovaro Biosciences Inc across 14 annual periods. See RENB net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Renovaro Biosciences Inc (2012–2025)
Year-by-year free cash flow to debt coverage for Renovaro Biosciences Inc. For the full company profile including market capitalisation, see how much is Renovaro Biosciences Inc worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.35x | $-10.90 Million | $-10.97 Million | $31.15 Million | ▲ +0.0% |
| 2024 | -0.35x | $-10.90 Million | $-10.97 Million | $31.15 Million | ▲ +64.8% |
| 2023 | -1.00x | $-11.74 Million | $-11.77 Million | $11.80 Million | ▲ +24.0% |
| 2022 | -1.31x | $-15.73 Million | $-15.73 Million | $12.01 Million | ▲ +4.9% |
| 2021 | -1.38x | $-20.56 Million | $-20.61 Million | $14.94 Million | ▼ -58.4% |
| 2020 | -0.87x | $-10.27 Million | $-10.46 Million | $11.83 Million | ▲ +24.4% |
| 2019 | -1.15x | $-7.79 Million | $-8.51 Million | $6.78 Million | ▼ -534.1% |
| 2018 | -0.18x | $-4.31 Million | $-4.34 Million | $23.76 Million | ▲ +52.8% |
| 2017 | -0.38x | $-1.15 Million | $-1.18 Million | $2.99 Million | ▲ +60.7% |
| 2016 | -0.98x | $-1.47 Million | $-1.47 Million | $1.51 Million | ▲ +15.7% |
| 2015 | -1.16x | $-2.03 Million | $-2.03 Million | $1.76 Million | ▼ -15.7% |
| 2014 | -1.00x | $-2.10 Million | $-2.13 Million | $2.10 Million | ▼ -136.7% |
| 2013 | -0.42x | $-30.09K | $-30.09K | $71.23K | ▲ +53.9% |
| 2012 | -0.92x | $-24.95K | $-24.95K | $27.23K | — |